The 15 year survival rate for Chronic Lymphocytic Leukemia (CLL) varies widely depending on the stage of the disease at diagnosis. Generally speaking, the overall 15 year survival rate for CLL is around 45%, with some studies suggesting an even lower rate of around 30%.
For early stage CLL patients, the 15 year survival rate is higher at around 78%. This rate decreases as the stage of the cancer progresses, with the 15 year survival rate for advanced stage CLL patients being around 15%.
The survival rate for CLL patients is also affected by other factors such as the patient’s age, sex, and the type of treatment they receive. Younger patients tend to have better survival rates than older patients, and males tend to have better survival rates than females. Additionally, patients who receive aggressive treatment with chemotherapy and/or radiation therapy tend to have better survival rates than those who do not receive treatment.
Overall, the 15 year survival rate for CLL varies widely depending on the stage of the disease and other factors such as the patient’s age, sex, and type of treatment. However, the overall rate for CLL is quite low at around 45%, and even lower for advanced stage CLL.